<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26888925</article-id>
<article-id pub-id-type="pmc">4756152</article-id>
<article-id pub-id-type="publisher-id">2921-15</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.2921-15.2016</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
<subj-group>
<subject>Neurobiology of Disease</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Guo</surname>
<given-names>Weirui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Molinaro</surname>
<given-names>Gemma</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Collins</surname>
<given-names>Katie A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hays</surname>
<given-names>Seth A.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4225-241X</contrib-id>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paylor</surname>
<given-names>Richard</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Worley</surname>
<given-names>Paul F.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Szumlinski</surname>
<given-names>Karen K.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huber</surname>
<given-names>Kimberly M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>University of Texas Southwestern Medical Center, Department of Neuroscience, Dallas, Texas 75390, </aff>
<aff id="aff2"><sup>2</sup>Department of Psychological and Brain Sciences, Neuroscience Research Institute, University of California, Santa Barbara, California 93106, </aff>
<aff id="aff3"><sup>3</sup>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, and </aff>
<aff id="aff4"><sup>4</sup>Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Dr. Kimberly M. Huber,
<addr-line>University of Texas, Southwestern Medical Center, Department of Neuroscience, Box 9111, Dallas, TX 75390-9111.</addr-line><email>Kimberly.Huber@UTSouthwestern.edu</email></corresp>
<fn fn-type="con">
<p>Author contributions: W.G., G.M., K.A.C., S.A.H., R.P., P.F.W., K.K.S., and K.M.H. designed research; W.G., G.M., K.A.C., S.A.H., R.P., and K.K.S. performed research; P.F.W. contributed unpublished reagents/analytic tools; W.G., G.M., K.A.C., S.A.H., R.P., K.K.S., and K.M.H. analyzed data; K.A.C., K.K.S., and K.M.H. wrote the paper.</p>
</fn>
<fn fn-type="equal" id="FN1">
<p>*W.G., G.M., and K.A.C. contributed equally to this study.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>17</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>8</month>
<year>2016</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>36</volume>
<issue>7</issue>
<fpage>2131</fpage>
<lpage>2147</lpage>
<history>
<date date-type="received">
<day>3</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>12</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>5</day>
<month>1</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2016 the authors 0270-6474/16/362131-17$15.00/0</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri xlink:href="zns00716002131.pdf" xlink:title="pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Altered function of the Gq-coupled, Group 1 metabotropic glutamate receptors, specifically mGlu5, is implicated in multiple mouse models of autism and intellectual disability. mGlu5 dysfunction has been most well characterized in the fragile X syndrome mouse model, the <italic>Fmr1</italic> knock-out (KO) mouse, where pharmacological and genetic reduction of mGlu5 reverses many phenotypes. mGlu5 is less associated with its scaffolding protein Homer in <italic>Fmr1</italic> KO mice, and restoration of mGlu5-Homer interactions by genetic deletion of a short, dominant negative of Homer, <italic>H1a</italic>, rescues many phenotypes of <italic>Fmr1</italic> KO mice. These results suggested that disruption of mGlu5-Homer leads to phenotypes of FXS. To test this idea, we examined mice with a knockin mutation of mGlu5 (F1128R; mGlu5<italic><sup>R/R</sup></italic>) that abrogates binding to Homer. Although FMRP levels were normal, mGlu5<italic><sup>R/R</sup></italic> mice mimicked multiple phenotypes of <italic>Fmr1</italic> KO mice, including reduced mGlu5 association with the postsynaptic density, enhanced constitutive mGlu5 signaling to protein synthesis, deficits in agonist-induced translational control, protein synthesis-independent LTD, neocortical hyperexcitability, audiogenic seizures, and altered behaviors, including anxiety and sensorimotor gating. These results reveal new roles for the Homer scaffolds in regulation of mGlu5 function and implicate a specific molecular mechanism in a complex brain disease.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Abnormal function of the metabotropic, or Gq-coupled, glutamate receptor 5 (mGlu5) has been implicated in neurodevelopmental disorders, including a genetic cause of intellectual disability and autism called fragile X syndrome. In brains of a mouse model of fragile X, mGlu5 is less associated with its binding partner Homer, a scaffolding protein that regulates mGlu5 localization to synapses and its ability to activate biochemical signaling pathways. Here we show that a mouse expressing a mutant mGlu5 that cannot bind to Homer is sufficient to mimic many of the biochemical, neurophysiological, and behavioral symptoms observed in the fragile X mouse. This work provides strong evidence that Homer-mGlu5 binding contributes to symptoms associated with neurodevelopmental disorders.</p>
</abstract>
<kwd-group>
<kwd>fragile X syndrome</kwd>
<kwd>Homer</kwd>
<kwd>LTD</kwd>
<kwd>mGluR5</kwd>
<kwd>protein synthesis</kwd>
<kwd>UP states</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>